KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arbutus Biopharma (ABUS) Shares Issued (2016 - 2025)

Arbutus Biopharma (ABUS) has disclosed Shares Issued for 13 consecutive years, with $5.4 million as the latest value for Q4 2025.

  • Quarterly Shares Issued changed N/A to $5.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.5 million through Dec 2025, down 75.7% year-over-year, with the annual reading at $5.5 million for FY2025, 1298.99% up from the prior year.
  • Shares Issued hit $5.4 million in Q4 2025 for Arbutus Biopharma, up from -$2.9 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $75.4 million in Q3 2021 to a low of -$2.9 million in Q3 2025.
  • Historically, Shares Issued has averaged $7.6 million across 5 years, with a median of $300000.0 in 2022.
  • Biggest five-year swings in Shares Issued: surged 3600.0% in 2023 and later crashed 1681.08% in 2025.
  • Year by year, Shares Issued stood at -$1.8 million in 2021, then surged by 115.53% to $274000.0 in 2022, then increased by 0.73% to $276000.0 in 2023, then tumbled by 32.97% to $185000.0 in 2024, then soared by 2796.76% to $5.4 million in 2025.
  • Business Quant data shows Shares Issued for ABUS at $5.4 million in Q4 2025, -$2.9 million in Q3 2025, and $453000.0 in Q2 2025.